Page 91 - Early Development News Today

Following a heart attack, the human body is incapable of repairing lost tissue due to the hearts inability to generate new muscle

/PRNewswire/ -- Cellenkos Inc, a clinical stage biotechnology company focused on the development of allogeneic, off-the-shelf, T regulatory cell therapies...

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced a collaboration and licensing agreement to create investigational ...

Toronto, ON (PRWEB) January 05, 2023 -- Navigating the small molecule CMC pathway from discovery to the clinic comes with its own set of challenges and

Collaboration will combine Moderna's mRNA technology with CytomX's Probody® Platform to generate and develop therapeutics for oncology and non-oncology conditionsCytomX to receive $35 million upfront payment

DUBLIN--(BUSINESS WIRE)--Dec 28, 2022--

JUNEAU (AP) — Alaska Gov. Mike Dunleavy has picked Heidi Hedberg to lead the state health department. She was previously the acting commissioner.

JUNEAU, Alaska (AP) — Alaska Gov. Mike Dunleavy has picked Heidi Hedberg to lead the state health department. She was previously the acting commissioner. Hedberg replaces Adam Crum, whom Dunleavy earlier appointed to lead the state Department of Revenue.

/PRNewswire/ -- Needle Free Injections Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022...

Xilis Announces Formation of its Scientific Advisory Board Company developing breakthrough clinically-predictive patient tumor avatar platform with native tumor–immune biology to accelerate drug discovery and development andrevolutionize patient care DURHAM, N.C. – December 15, 2022 – Xil...